1. Home
  2. NEON vs DCTH Comparison

NEON vs DCTH Comparison

Compare NEON & DCTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NEON
  • DCTH
  • Stock Information
  • Founded
  • NEON 1997
  • DCTH 1988
  • Country
  • NEON Sweden
  • DCTH United States
  • Employees
  • NEON N/A
  • DCTH N/A
  • Industry
  • NEON Industrial Machinery/Components
  • DCTH Medical/Dental Instruments
  • Sector
  • NEON Technology
  • DCTH Health Care
  • Exchange
  • NEON Nasdaq
  • DCTH Nasdaq
  • Market Cap
  • NEON 428.0M
  • DCTH 426.3M
  • IPO Year
  • NEON 2007
  • DCTH N/A
  • Fundamental
  • Price
  • NEON $26.18
  • DCTH $11.87
  • Analyst Decision
  • NEON Strong Buy
  • DCTH Strong Buy
  • Analyst Count
  • NEON 1
  • DCTH 4
  • Target Price
  • NEON $16.50
  • DCTH $24.00
  • AVG Volume (30 Days)
  • NEON 763.4K
  • DCTH 873.0K
  • Earning Date
  • NEON 08-07-2025
  • DCTH 08-04-2025
  • Dividend Yield
  • NEON N/A
  • DCTH N/A
  • EPS Growth
  • NEON N/A
  • DCTH N/A
  • EPS
  • NEON N/A
  • DCTH N/A
  • Revenue
  • NEON $2,807,000.00
  • DCTH $53,850,000.00
  • Revenue This Year
  • NEON N/A
  • DCTH $162.10
  • Revenue Next Year
  • NEON $39.01
  • DCTH $32.97
  • P/E Ratio
  • NEON N/A
  • DCTH N/A
  • Revenue Growth
  • NEON N/A
  • DCTH 1068.87
  • 52 Week Low
  • NEON $2.22
  • DCTH $7.17
  • 52 Week High
  • NEON $28.08
  • DCTH $18.23
  • Technical
  • Relative Strength Index (RSI)
  • NEON 69.54
  • DCTH 34.38
  • Support Level
  • NEON $24.31
  • DCTH $11.20
  • Resistance Level
  • NEON $28.08
  • DCTH $12.72
  • Average True Range (ATR)
  • NEON 2.04
  • DCTH 0.61
  • MACD
  • NEON -0.09
  • DCTH -0.15
  • Stochastic Oscillator
  • NEON 76.86
  • DCTH 22.52

About NEON Neonode Inc.

Neonode Inc provides optical sensing solutions for contactless touch, and gesture sensing and also provides software solutions for machine perception that feature machine learning algorithms to detect and track persons and objects in video streams from cameras and other types of imagers. It markets and sells its solutions to customers in many different markets and segments including, but not limited to, office equipment, automotive, industrial automation, medical, military, and avionics. The company geographically operates in the United States, Japan, South Korea, Germany, Sweden, China, and other regions. A majority of its revenue is generated from Japan.

About DCTH Delcath Systems Inc.

Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.

Share on Social Networks: